TANNENBAUM RENEE P
SEC CIK 1543174 · EDGAR
BoughtSold
Most active insiders at ANIP, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Lalwani Nikhil | Pres, CEO, Dir | — | $5.05M |
| 2 | Walsh Patrick D | Dir | — | $2.32M |
| 3 | CAREY STEPHEN P. | SVP, CFO | — | $1.78M |
| 4 | Mutz Christopher | HEAD OF RARE DISEASE | — | $1.64M |
| 5 | Gassert Chad | SVP - CORP. DEV, STRATEGY | — | $1.31M |
| 6 | Davis Krista | SVP, Chief HR Off | — | $918.6K |
| 7 | Gutwerg Ori | SVP, GENERICS | — | $621.4K |
| 8 | Cook Meredith | SVP, GC, SEC | — | $453.9K |
| 9 | Rowland Thomas Andrew | SVP, HEAD - ESTABLISHED BRANDS | — | $393.8K |
| 10 | HAUGHEY THOMAS | Dir | — | $161.8K |
| 11 | TANNENBAUM RENEE P | Dir | — | $146.1K |
Transactions 9
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-10 21:09 | 2026-05-21 | ANIP | ANI PHARMACEUTICALS INC | TANNENBAUM RENEE P | Dir | A - Grant | $0.00 | +4,357 | 29.5K | +17% | $0 | |
| 2025-12-09 | 2025-12-05 | ANIP | ANI PHARMACEUTICALS INC | TANNENBAUM RENEE P | Dir | S - Sale | $81.15 | -1,800 | 25.2K | -7% | -$146.1K | |
| 2025-05-27 | 2025-05-22 | ANIP | ANI PHARMACEUTICALS INC | TANNENBAUM RENEE P | Dir | A - Grant | $0.00 | +4,336 | 27.0K | +19% | $0 | |
| 2024-12-16 | 2024-12-12 | CRDF | Cardiff Oncology, Inc. | TANNENBAUM RENEE P | Dir | P - Purchase | $3.42 | +10.0K | 20.0K | +100% | +$34.2K | |
| 2024-05-23 | 2024-05-21 | ANIP | ANI PHARMACEUTICALS INC | TANNENBAUM RENEE P | Dir | A - Grant | $0.00 | +4,410 | 22.6K | +24% | $0 | |
| 2024-05-17 | 2024-05-16 | ANIP | ANI PHARMACEUTICALS INC | TANNENBAUM RENEE P | Dir | S - Sale | $63.87 | -2,000 | 18.2K | -10% | -$127.7K | |
| 2023-05-24 | 2023-05-23 | ANIP | ANI PHARMACEUTICALS INC | TANNENBAUM RENEE P | Dir | A - Grant | $0.00 | +6,865 | 20.2K | +51% | $0 | |
| M | 2022-09-19 | 2022-09-15 | CRDF | Cardiff Oncology, Inc. | TANNENBAUM RENEE P | Dir | P - Purchase | $1.72 | +10.0K | 10.0K | New | +$17.2K |
| 2022-03-22 | 2022-03-19 | ANIP | ANI PHARMACEUTICALS INC | TANNENBAUM RENEE P | Dir | A - Grant | $0.00 | +13.3K | 13.3K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations